RENULYS
Welcome to the Brand page for “RENULYS”, which is offered here for Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of sickle cell disease;.
Its status is currently believed to be active. Its class is unavailable. “RENULYS” is believed to be currently owned by “Pfizer Inc.”
| Owner: |
PFIZER INC.
Owner Details |
|---|---|
| Description: |
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of sickle cell disease;
|
| Categories: | PHARMACEUTICAL PREPARATIONS TREATMENT |
